Skip navigation | ||
|
||
WORCESTER, England, Oct 14, 2004 (United Press International via COMTEX) -- A deadly bacteria known to infect hospital patients may be vulnerable to a new treatment, British researchers said.
As reported in New Scientist magazine, the bacteria, MRSA -- also known as the "hospital superbug" -- is highly resistant to conventional antibiotics and kills up to 20,000 people a year in the United Kingdom.
Researchers at the company Pharmaceutica said they may have found a compound that breaks down the bacteria's defenses and leaves it vulnerable to ordinary antibacterial treatments. The compound contains a commonly available amino acid called glycine, which alters the cell walls of MRSA, allowing antibiotics to work.
One such antibiotic, called methicillin -- like penicillin -- can break down staphylococcus bacteria and render them harmless. Some of these bacteria, however, have evolved to resist methicillin. MRSA stands for methicillin-resistant Staphylococcus aureus.
Related MedlinePlus Pages:
Home | Health Topics | Drug Information | Encyclopedia | Dictionary | News | Directories | Other Resources | |
Copyright | Privacy | Accessibility | Selection Guidelines U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894 National Institutes of Health | Department of Health & Human Services |
Page last updated: 15 October 2004 |